Table 2 Relationship between expression of SOX2/CCAT1 and clinicopathological features in patients with CC
Clinicopathologic data | n | Expression of SOX2 | P | Expression of CCAT1 | P | ||
---|---|---|---|---|---|---|---|
Low expression group (n = 19) | High expression group (n = 20) | Low expression group (n = 19) | High expression group (n = 20) | ||||
Age (year) | |||||||
≤ 60 | 18 | 8 | 10 | 0.751 | 7 | 11 | 0.341 |
> 60 | 21 | 11 | 10 | 12 | 9 | ||
History of gynecological infection | |||||||
Yes | 26 | 12 | 14 | 0.741 | 10 | 16 | 0.096 |
No | 13 | 7 | 6 | 9 | 4 | ||
Cancer tissue size (cm) | |||||||
≤ 4 | 17 | 12 | 5 | 0.025 | 13 | 4 | 0.004 |
> 4 | 22 | 7 | 15 | 6 | 16 | ||
LNM | |||||||
N0 | 23 | 15 | 8 | 0.023 | 17 | 6 | < 0.001 |
N1–N3 | 16 | 4 | 12 | 2 | 14 | ||
FIGO stage | |||||||
I–II | 18 | 14 | 4 | 0.001 | 13 | 5 | 0.010 |
III–IV | 21 | 5 | 16 | 6 | 15 | ||
Differentiation degree | |||||||
Low | 18 | 7 | 11 | 0.341 | 6 | 12 | 0.111 |
High and middle | 21 | 12 | 9 | 13 | 8 | ||
Pathological type | |||||||
Squamous cancer | 21 | 9 | 12 | 0.527 | 10 | 11 | 1.000 |
Adenocarcinoma | 18 | 10 | 8 | 9 | 9 |